Daniel Schrimpf Selected Research

Nervous System Neoplasms (Neoplasms, Nervous System)

1/2019	Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profiles.
3/2015	Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Schrimpf Research Topics

Disease

31	Neoplasms (Cancer) 12/2022 - 01/2015
12	Glioma (Gliomas) 12/2022 - 01/2015
7	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2015
6	Astrocytoma (Pilocytic Astrocytoma) 12/2022 - 01/2015
5	Medulloblastoma 01/2022 - 01/2016
4	Sarcoma (Soft Tissue Sarcoma) 07/2021 - 01/2016
3	Meningioma (Meningiomas) 01/2022 - 01/2019
2	Oligodendroglioma 12/2022 - 01/2015
2	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 01/2017
2	Disease Progression 01/2021 - 01/2020
2	Primitive Neuroectodermal Tumors (PNET) 01/2021 - 01/2016
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2018
2	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2016
2	Nervous System Neoplasms (Neoplasms, Nervous System) 01/2019 - 03/2015
1	Pleomorphic Adenoma 11/2021
1	Soft Tissue Neoplasms 07/2021
1	Solitary Fibrous Tumors 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Pleurisy (Pleuritis) 01/2021
1	Fibroma (Fibromatosis) 01/2021
1	Fasciitis (Fascitis) 01/2021
1	Turcot syndrome 01/2021
1	Hemangiosarcoma (Angiosarcoma) 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Hyperplasia 01/2021
1	Leiomyosarcoma 01/2021
1	Aggressive Fibromatosis (Desmoid) 01/2021
1	Synovial Sarcoma (Synovioma) 01/2021
1	Monosomy 01/2019
1	Genomic Instability 01/2019
1	Necrosis 11/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Chondrosarcoma 01/2017
1	Giant Cell Tumors (Giant Cell Tumor) 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017
1	Cholangiocarcinoma 01/2017
1	Chondroblastoma 01/2017
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 01/2016
1	Vision Disorders (Hemeralopia) 01/2016
1	Hemianopsia (Bitemporal Hemianopsia) 01/2016
1	Neurilemmoma (Schwannoma) 01/2016
1	Neurofibrosarcoma (MPNST) 01/2016

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 12/2022 - 05/2015
6	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2020
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2017
6	RNA (Ribonucleic Acid)IBA 11/2021 - 01/2019
5	Biological ProductsIBA 01/2021 - 03/2015
4	Formaldehyde (Formol)FDA Link 12/2022 - 05/2015
4	ParaffinIBA 12/2022 - 05/2015
3	Histones (Histone)IBA 01/2019 - 01/2016
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2020 - 11/2019
2	NucleotidesIBA 01/2019 - 01/2016
2	1,4-dinitro-2-methyl-2-buteneIBA 01/2019 - 12/2016
1	VimentinIBA 12/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	ProteomeIBA 01/2022
1	Reticulin (Reticular Fiber)IBA 01/2022
1	Pharmaceutical PreparationsIBA 12/2021
1	A-Form DNA (A-DNA)IBA 07/2021
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021
1	1-methyl-1-piperidinomethane sulfonateIBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2020
1	NeurocalcinIBA 01/2020
1	CateninsIBA 01/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	VaccinesIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	antiarrhythmic peptide (AAP)IBA 01/2018
1	thiamine triphosphorate (TTP)IBA 01/2018
1	PolyaminesIBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	MethyltransferasesIBA 01/2018
1	EnzymesIBA 01/2017
1	Codon (Codons)IBA 01/2017
1	BAY 1436032IBA 01/2017
1	alpha-hydroxyglutarateIBA 01/2017
1	Neurofibromin 1 (Neurofibromin)IBA 01/2016
1	ProlactinIBA 01/2016

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2015
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
1	Immunotherapy 01/2021
1	Investigational Therapies (Experimental Therapy) 01/2016